Department of Pharmaceutical Sciences, Zunyi Medical University, Zhuhai Campus, Zhuhai 519041, PR China.
College of Pharmacy, Zunyi Medical University, Zunyi 563000, PR China.
J Agric Food Chem. 2021 Nov 24;69(46):13772-13779. doi: 10.1021/acs.jafc.1c04801. Epub 2021 Nov 12.
Urease is a metalloenzyme that catalyzes the hydrolysis of urea into ammonia and carbon dioxide, which has a negative impact on human health and agriculture. In this study, the inactivation of jack bean urease by nitidine chloride (NC) was investigated to elucidate the inhibitory effect, kinetics, and underlying mechanism of action. The results showed that NC acted as a concentration- and time-dependent inhibitor with an IC value of 33.2 ± 4.8 μM and exhibited a similar inhibitory effect to acetohydroxamic acid (IC = 31.7 ± 5.8 μM). Further kinetic analysis demonstrated that NC was a slow-binding and non-competitive inhibitor for urease. Thiol-blocking reagents (dithiothreitol, glutathione, and l-cysteine) significantly retarded urease inactivation, while Ni competitive inhibitors (boric acid and sodium fluoride) synergetically suppressed urease with NC, suggesting that the active site sulfhydryl groups were possibly obligatory for NC blocking urease. Molecular docking simulation further argued its inhibition mechanism. Additionally, NC-induced deactivation of urease was verified to be reversible since the inactivated enzyme could be reactivated by glutathione. Taking together, NC was a non-competitive inhibitor targeting the thiol group at the active site of urease with characteristics of concentration dependence, reversibility, and slow binding, serving as a promising novel urease suppressant.
脲酶是一种金属酶,能催化尿素水解为氨和二氧化碳,对人体健康和农业有负面影响。在这项研究中,研究了小檗胺(NC)对刀豆脲酶的失活作用,以阐明其抑制作用、动力学和作用机制。结果表明,NC 是一种浓度和时间依赖性抑制剂,IC 值为 33.2 ± 4.8 μM,对乙酰氧肟酸(IC = 31.7 ± 5.8 μM)的抑制作用相似。进一步的动力学分析表明,NC 是脲酶的慢结合非竞争性抑制剂。巯基阻断试剂(二硫苏糖醇、谷胱甘肽和半胱氨酸)显著减缓脲酶失活,而 Ni 竞争性抑制剂(硼酸和氟化钠)与 NC 协同抑制脲酶,表明活性部位巯基可能是 NC 阻断脲酶所必需的。分子对接模拟进一步证明了其抑制机制。此外,NC 诱导的脲酶失活被证实是可逆的,因为失活的酶可以通过谷胱甘肽重新激活。综上所述,NC 是一种非竞争性抑制剂,靶向脲酶活性部位的巯基基团,具有浓度依赖性、可逆性和慢结合的特点,是一种很有前途的新型脲酶抑制剂。